Dimethyltryptamine molecule:

Image from PubChem

DMT Clinical Trials

25 record(s) found.

Entheogen: dimethyltryptamine
Study Title: Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study
Start Date: Sep 01, 2022 - Last Update: May 20, 2022
Conditions: Healthy
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: A Phase 2 Clinical Trial of GH001 in Patients with Bipolar II Disorder and a Current Major Depressive Episode (GH001-BD-202)
Start Date: Jun 20, 2022
Conditions: Bipolar II Disorder
Location(s): Netherlands
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: dimethyltryptamine
Study Title: Psilocybin Therapy for Chronic Low Back Pain
Start Date: Jun 01, 2022 - Last Update: May 4, 2022
Conditions: Chronic Low-back Pain
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Personality and Drug Use (PDU)
Start Date: Apr 01, 2022 - Last Update: April 29, 2022
Conditions: Personality
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Start Date: Mar 03, 2022 - Last Update: March 29, 2022
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Single Ascending Dose Study With BPL-003 in Healthy Subjects
Start Date: Feb 14, 2022 - Last Update: April 26, 2022
Conditions: Pharmacokinetics in Healthy Adults
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Psilocybin Therapy for Depression in Bipolar II Disorder
Start Date: Jan 28, 2022 - Last Update: February 1, 2022
Conditions: Bipolar II Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
Start Date: Sep 22, 2021 - Last Update: April 4, 2022
Conditions: Pharmacokinetics in Healthy Adults
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Start Date: Aug 15, 2021 - Last Update: September 5, 2021
Conditions: Parkinson Disease, Depression, Anxiety
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Pharmacokinetics of GH001 in Healthy Volunteers
Start Date: Jun 21, 2021 - Last Update: December 20, 2021
Conditions: Healthy Volunteers
Location(s): Netherlands
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Effects of Dimethyltryptamine in Healthy Subjects
Start Date: Jun 18, 2021 - Last Update: August 18, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Start Date: Apr 14, 2021 - Last Update: April 15, 2022
Conditions: Major Depressive Disorder, Alcohol Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
Start Date: Mar 17, 2021 - Last Update: February 10, 2022
Conditions: Major Depressive Disorder, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
Start Date: Feb 04, 2021 - Last Update: December 23, 2021
Conditions: Major Depressive Disorder
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects
Start Date: Dec 01, 2020 - Last Update: November 15, 2021
Conditions: Emotions, Mood, Cognitive Function 1, Social, Empathy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Clinical Study of GH001 in Depression
Start Date: Nov 12, 2019 - Last Update: December 20, 2021
Conditions: Treatment Resistant Depression, Major Depressive Disorder, Depression
Location(s): Netherlands
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: A phase 1/2 study of GH001 in patients with treatment-resistant depression
Start Date: Aug 21, 2019
Conditions: Treatment-resistant depression
Location(s): Netherlands
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: dimethyltryptamine
Study Title: Safety of GH001 in Healthy Volunteers
Start Date: Mar 13, 2019 - Last Update: November 23, 2020
Conditions: Healthy Volunteers
Location(s): Netherlands
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Start Date: Jan 05, 2018 - Last Update: January 7, 2021
Conditions: Distress, Depression, Grief
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: UW Psilocybin Pharmacokinetics Study
Start Date: Jun 01, 2014 - Last Update: April 15, 2020
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Start Date: May 01, 2014 - Last Update: December 30, 2019
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression
Start Date: Feb 01, 2014 - Last Update: February 17, 2017
Conditions: Major Depression
Location(s): Brazil
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Psilocybin Cancer Anxiety Study
Start Date: Feb 01, 2009 - Last Update: October 20, 2020
Conditions: Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Start Date: Sep 01, 2008 - Last Update: October 4, 2021
Conditions: Nicotine Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Psychopharmacology of Psilocybin in Cancer Patients
Start Date: Apr 01, 2007 - Last Update: July 19, 2018
Conditions: Depressive Symptoms, Anxiety, Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary



Total execution time in seconds: 0.042475938796997